Draft. Highlighted text is still to be confirmed.

What is ibogaine?

A medicine from the root bark of an African shrub, with a long ceremonial history, a short scientific one, and real risks.

Ibogaine comes from the root bark of iboga, a shrub of the Central West African forest. For generations it has stood at the center of Bwiti, a spiritual tradition in Gabon, where the root is taken in ceremony. That tradition has long described the passage as a death and a return, a way of meeting one’s ancestors and oneself.

People who take it often speak of a long waking dream: a panoramic review of a life, memory by memory, with nowhere to look away. Word traveled that a single sitting could interrupt the grip of opioids. That reputation began as a story, moved through rooms outside the United States, and has since reached veterans, researchers, public conversation, and even statehouses.

In the United States, ibogaine is not approved by the FDA, which is why the twelve travel to Mexico. A Chance to Live is here to document the experience itself: what it looks like, what it asks of someone, and what follows when they come home.

What the research says

The best-known modern study came from Stanford in 2024. Thirty special operations veterans with traumatic brain injuries, who had arranged their own treatment at a clinic in Mexico, took ibogaine together with magnesium. One month later their PTSD symptoms had fallen by 88 percent on average, depression by 87 percent and anxiety by 81 percent. Their average disability score dropped from 30.2 to 5.1. The researchers reported no serious side effects.12

The limits matter as much as the numbers. It was a small study with no comparison group, every participant was a veteran, the results cover one month, and it was not a study of addiction. Findings like these still have to be confirmed in larger, controlled trials.

The risks

Ibogaine can be dangerous, and people have died after taking it. It changes the heart’s rhythm by lengthening what doctors call the QT interval, which can set off a fatal arrhythmia.

A medical review counted 19 deaths linked in time to ibogaine between 1990 and 2008, six of them from acute heart failure or cardiopulmonary arrest, and found that heart problems can appear days after a single dose. The danger is greater for people with existing heart conditions and for people taking certain medications or other drugs. The reviewers concluded that ibogaine should only be given under strict medical observation, with continuous heart monitoring.3

This is why screening comes first. Every applicant is screened by the clinic’s medical team before they raise any money, and the doctors can say no at any point, including on the day of treatment.

What the clinic does about the risk

To be confirmed with Clear Ibogaine before launch. Edit this list in site.json, then set safetyConfirmed to true.

  • A physician and a nurse are on site through dosing and the first 24 hours.
  • Continuous ECG, blood pressure and oxygen monitoring, with IV access placed before dosing.
  • Emergency medications, a defibrillator and ACLS-certified staff on site.
  • EKG, labs and a medication review before travel, with a cardiology read when a result is borderline.
  • A named transfer hospital minutes away, with a written emergency plan.

Is it legal?

In the United States, ibogaine has been a Schedule I controlled substance since 1970, and the FDA has not approved it for any use.2 In April 2026 a presidential executive order told federal agencies to speed up the research and review of psychedelic medicines, ibogaine among them. It did not change ibogaine’s legal status.4

Clinics in Mexico offer ibogaine treatment legally,2 which is why the twelve travel to Rosarito.

This is not medical advice

A Chance to Live is a documentary, not a medical provider. Nothing on this site is medical advice, and raising money is not admission to treatment. If you are thinking about ibogaine, talk with a doctor who knows your history, especially your heart and your medications.

Sources

  1. Cherian K.N. et al. “Magnesium–ibogaine therapy in veterans with traumatic brain injuries.” Nature Medicine 30, 373–381 (2024). nature.com/articles/s41591-023-02705-w
  2. Stanford Medicine news release on the same study, January 5, 2024. med.stanford.edu/news/all-news/2024/01/ibogaine-ptsd.html
  3. Koenig X., Hilber K. “The anti-addiction drug ibogaine and the heart: a delicate relation.” Molecules 20(2), 2208–2228 (2015). pmc.ncbi.nlm.nih.gov/articles/PMC4382526
  4. Executive Order 14401, “Accelerating Medical Treatments for Serious Mental Illness,” April 18, 2026. whitehouse.gov/presidential-actions/2026/04/accelerating-medical-treatments-for-serious-mental-illness

See who is going.